Differentiated Thyroid Cancer Treatment Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Differentiated Thyroid Cancer Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Radioiodine Ablation
1.2.3 Thyroid Stimulating Hormone (THS) Suppression
1.2.4 Chemotherapy
1.2.5 Targeted Multikinase Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Differentiated Thyroid Cancer Treatment Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Oncology Canters
1.3.4 Hospital Pharmacies
1.3.5 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Differentiated Thyroid Cancer Treatment Market Perspective (2017-2028)
2.2 Differentiated Thyroid Cancer Treatment Growth Trends by Region
2.2.1 Differentiated Thyroid Cancer Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Differentiated Thyroid Cancer Treatment Historic Market Size by Region (2017-2022)
2.2.3 Differentiated Thyroid Cancer Treatment Forecasted Market Size by Region (2023-2028)
2.3 Differentiated Thyroid Cancer Treatment Market Dynamics
2.3.1 Differentiated Thyroid Cancer Treatment Industry Trends
2.3.2 Differentiated Thyroid Cancer Treatment Market Drivers
2.3.3 Differentiated Thyroid Cancer Treatment Market Challenges
2.3.4 Differentiated Thyroid Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Differentiated Thyroid Cancer Treatment Players by Revenue
3.1.1 Global Top Differentiated Thyroid Cancer Treatment Players by Revenue (2017-2022)
3.1.2 Global Differentiated Thyroid Cancer Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Differentiated Thyroid Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Differentiated Thyroid Cancer Treatment Revenue
3.4 Global Differentiated Thyroid Cancer Treatment Market Concentration Ratio
3.4.1 Global Differentiated Thyroid Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Differentiated Thyroid Cancer Treatment Revenue in 2021
3.5 Differentiated Thyroid Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Differentiated Thyroid Cancer Treatment Product Solution and Service
3.7 Date of Enter into Differentiated Thyroid Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Differentiated Thyroid Cancer Treatment Breakdown Data by Type
4.1 Global Differentiated Thyroid Cancer Treatment Historic Market Size by Type (2017-2022)
4.2 Global Differentiated Thyroid Cancer Treatment Forecasted Market Size by Type (2023-2028)
5 Differentiated Thyroid Cancer Treatment Breakdown Data by Application
5.1 Global Differentiated Thyroid Cancer Treatment Historic Market Size by Application (2017-2022)
5.2 Global Differentiated Thyroid Cancer Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Differentiated Thyroid Cancer Treatment Market Size (2017-2028)
6.2 North America Differentiated Thyroid Cancer Treatment Market Size by Country (2017-2022)
6.3 North America Differentiated Thyroid Cancer Treatment Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Differentiated Thyroid Cancer Treatment Market Size (2017-2028)
7.2 Europe Differentiated Thyroid Cancer Treatment Market Size by Country (2017-2022)
7.3 Europe Differentiated Thyroid Cancer Treatment Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size (2017-2028)
8.2 Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size by Country (2017-2022)
8.3 Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Differentiated Thyroid Cancer Treatment Market Size (2017-2028)
9.2 Latin America Differentiated Thyroid Cancer Treatment Market Size by Country (2017-2022)
9.3 Latin America Differentiated Thyroid Cancer Treatment Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size (2017-2028)
10.2 Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size by Country (2017-2022)
10.3 Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Mylan pharmaceuticals
11.1.1 Mylan pharmaceuticals Company Detail
11.1.2 Mylan pharmaceuticals Business Overview
11.1.3 Mylan pharmaceuticals Differentiated Thyroid Cancer Treatment Introduction
11.1.4 Mylan pharmaceuticals Revenue in Differentiated Thyroid Cancer Treatment Business (2017-2022)
11.1.5 Mylan pharmaceuticals Recent Development
11.2 Takeda
11.2.1 Takeda Company Detail
11.2.2 Takeda Business Overview
11.2.3 Takeda Differentiated Thyroid Cancer Treatment Introduction
11.2.4 Takeda Revenue in Differentiated Thyroid Cancer Treatment Business (2017-2022)
11.2.5 Takeda Recent Development
11.3 Alara Pharmaceutical
11.3.1 Alara Pharmaceutical Company Detail
11.3.2 Alara Pharmaceutical Business Overview
11.3.3 Alara Pharmaceutical Differentiated Thyroid Cancer Treatment Introduction
11.3.4 Alara Pharmaceutical Revenue in Differentiated Thyroid Cancer Treatment Business (2017-2022)
11.3.5 Alara Pharmaceutical Recent Development
11.4 Abbott laboratories
11.4.1 Abbott laboratories Company Detail
11.4.2 Abbott laboratories Business Overview
11.4.3 Abbott laboratories Differentiated Thyroid Cancer Treatment Introduction
11.4.4 Abbott laboratories Revenue in Differentiated Thyroid Cancer Treatment Business (2017-2022)
11.4.5 Abbott laboratories Recent Development
11.5 Bristol Myers
11.5.1 Bristol Myers Company Detail
11.5.2 Bristol Myers Business Overview
11.5.3 Bristol Myers Differentiated Thyroid Cancer Treatment Introduction
11.5.4 Bristol Myers Revenue in Differentiated Thyroid Cancer Treatment Business (2017-2022)
11.5.5 Bristol Myers Recent Development
11.6 Teva
11.6.1 Teva Company Detail
11.6.2 Teva Business Overview
11.6.3 Teva Differentiated Thyroid Cancer Treatment Introduction
11.6.4 Teva Revenue in Differentiated Thyroid Cancer Treatment Business (2017-2022)
11.6.5 Teva Recent Development
11.7 Jerome Stevens
11.7.1 Jerome Stevens Company Detail
11.7.2 Jerome Stevens Business Overview
11.7.3 Jerome Stevens Differentiated Thyroid Cancer Treatment Introduction
11.7.4 Jerome Stevens Revenue in Differentiated Thyroid Cancer Treatment Business (2017-2022)
11.7.5 Jerome Stevens Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Differentiated Thyroid Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Radioiodine Ablation
Table 3. Key Players of Thyroid Stimulating Hormone (THS) Suppression
Table 4. Key Players of Chemotherapy
Table 5. Key Players of Targeted Multikinase Therapy
Table 6. Key Players of Others
Table 7. Global Differentiated Thyroid Cancer Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Differentiated Thyroid Cancer Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Differentiated Thyroid Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Differentiated Thyroid Cancer Treatment Market Share by Region (2017-2022)
Table 11. Global Differentiated Thyroid Cancer Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Differentiated Thyroid Cancer Treatment Market Share by Region (2023-2028)
Table 13. Differentiated Thyroid Cancer Treatment Market Trends
Table 14. Differentiated Thyroid Cancer Treatment Market Drivers
Table 15. Differentiated Thyroid Cancer Treatment Market Challenges
Table 16. Differentiated Thyroid Cancer Treatment Market Restraints
Table 17. Global Differentiated Thyroid Cancer Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Differentiated Thyroid Cancer Treatment Market Share by Players (2017-2022)
Table 19. Global Top Differentiated Thyroid Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Differentiated Thyroid Cancer Treatment as of 2021)
Table 20. Ranking of Global Top Differentiated Thyroid Cancer Treatment Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Differentiated Thyroid Cancer Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Differentiated Thyroid Cancer Treatment Product Solution and Service
Table 24. Date of Enter into Differentiated Thyroid Cancer Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Differentiated Thyroid Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Differentiated Thyroid Cancer Treatment Revenue Market Share by Type (2017-2022)
Table 28. Global Differentiated Thyroid Cancer Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Differentiated Thyroid Cancer Treatment Revenue Market Share by Type (2023-2028)
Table 30. Global Differentiated Thyroid Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Differentiated Thyroid Cancer Treatment Revenue Market Share by Application (2017-2022)
Table 32. Global Differentiated Thyroid Cancer Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Differentiated Thyroid Cancer Treatment Revenue Market Share by Application (2023-2028)
Table 34. North America Differentiated Thyroid Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Differentiated Thyroid Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Differentiated Thyroid Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Differentiated Thyroid Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Differentiated Thyroid Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Differentiated Thyroid Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 44. Mylan pharmaceuticals Company Detail
Table 45. Mylan pharmaceuticals Business Overview
Table 46. Mylan pharmaceuticals Differentiated Thyroid Cancer Treatment Product
Table 47. Mylan pharmaceuticals Revenue in Differentiated Thyroid Cancer Treatment Business (2017-2022) & (US$ Million)
Table 48. Mylan pharmaceuticals Recent Development
Table 49. Takeda Company Detail
Table 50. Takeda Business Overview
Table 51. Takeda Differentiated Thyroid Cancer Treatment Product
Table 52. Takeda Revenue in Differentiated Thyroid Cancer Treatment Business (2017-2022) & (US$ Million)
Table 53. Takeda Recent Development
Table 54. Alara Pharmaceutical Company Detail
Table 55. Alara Pharmaceutical Business Overview
Table 56. Alara Pharmaceutical Differentiated Thyroid Cancer Treatment Product
Table 57. Alara Pharmaceutical Revenue in Differentiated Thyroid Cancer Treatment Business (2017-2022) & (US$ Million)
Table 58. Alara Pharmaceutical Recent Development
Table 59. Abbott laboratories Company Detail
Table 60. Abbott laboratories Business Overview
Table 61. Abbott laboratories Differentiated Thyroid Cancer Treatment Product
Table 62. Abbott laboratories Revenue in Differentiated Thyroid Cancer Treatment Business (2017-2022) & (US$ Million)
Table 63. Abbott laboratories Recent Development
Table 64. Bristol Myers Company Detail
Table 65. Bristol Myers Business Overview
Table 66. Bristol Myers Differentiated Thyroid Cancer Treatment Product
Table 67. Bristol Myers Revenue in Differentiated Thyroid Cancer Treatment Business (2017-2022) & (US$ Million)
Table 68. Bristol Myers Recent Development
Table 69. Teva Company Detail
Table 70. Teva Business Overview
Table 71. Teva Differentiated Thyroid Cancer Treatment Product
Table 72. Teva Revenue in Differentiated Thyroid Cancer Treatment Business (2017-2022) & (US$ Million)
Table 73. Teva Recent Development
Table 74. Jerome Stevens Company Detail
Table 75. Jerome Stevens Business Overview
Table 76. Jerome Stevens Differentiated Thyroid Cancer Treatment Product
Table 77. Jerome Stevens Revenue in Differentiated Thyroid Cancer Treatment Business (2017-2022) & (US$ Million)
Table 78. Jerome Stevens Recent Development
Table 79. Research Programs/Design for This Report
Table 80. Key Data Information from Secondary Sources
Table 81. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Differentiated Thyroid Cancer Treatment Market Share by Type: 2021 VS 2028
Figure 2. Radioiodine Ablation Features
Figure 3. Thyroid Stimulating Hormone (THS) Suppression Features
Figure 4. Chemotherapy Features
Figure 5. Targeted Multikinase Therapy Features
Figure 6. Others Features
Figure 7. Global Differentiated Thyroid Cancer Treatment Market Share by Application in 2021 & 2028
Figure 8. Hospitals Case Studies
Figure 9. Oncology Canters Case Studies
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Differentiated Thyroid Cancer Treatment Report Years Considered
Figure 13. Global Differentiated Thyroid Cancer Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Differentiated Thyroid Cancer Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Differentiated Thyroid Cancer Treatment Market Share by Region: 2021 VS 2028
Figure 16. Global Differentiated Thyroid Cancer Treatment Market Share by Players in 2021
Figure 17. Global Top Differentiated Thyroid Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Differentiated Thyroid Cancer Treatment as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Differentiated Thyroid Cancer Treatment Revenue in 2021
Figure 19. North America Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. North America Differentiated Thyroid Cancer Treatment Market Share by Country (2017-2028)
Figure 21. United States Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Differentiated Thyroid Cancer Treatment Market Share by Country (2017-2028)
Figure 25. Germany Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Differentiated Thyroid Cancer Treatment Market Share by Region (2017-2028)
Figure 33. China Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Japan Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. South Korea Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Southeast Asia Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. India Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Australia Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Differentiated Thyroid Cancer Treatment Market Share by Country (2017-2028)
Figure 41. Mexico Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Brazil Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Differentiated Thyroid Cancer Treatment Market Share by Country (2017-2028)
Figure 45. Turkey Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Saudi Arabia Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Mylan pharmaceuticals Revenue Growth Rate in Differentiated Thyroid Cancer Treatment Business (2017-2022)
Figure 48. Takeda Revenue Growth Rate in Differentiated Thyroid Cancer Treatment Business (2017-2022)
Figure 49. Alara Pharmaceutical Revenue Growth Rate in Differentiated Thyroid Cancer Treatment Business (2017-2022)
Figure 50. Abbott laboratories Revenue Growth Rate in Differentiated Thyroid Cancer Treatment Business (2017-2022)
Figure 51. Bristol Myers Revenue Growth Rate in Differentiated Thyroid Cancer Treatment Business (2017-2022)
Figure 52. Teva Revenue Growth Rate in Differentiated Thyroid Cancer Treatment Business (2017-2022)
Figure 53. Jerome Stevens Revenue Growth Rate in Differentiated Thyroid Cancer Treatment Business (2017-2022)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Industry Market Size
